Adam Berlin is an associate in the firm’s Houston office. He is a member of the Pharma and BioPharma Litigation practice group. His primary area of focus is Hatch-Waxman litigation.
Prior to joining the firm, Adam was an intern at an Austin firm where he focused on indigent defense, police misconduct, and parental right advocacy. Adam was also a summer intern at K&L Gates where he studied Hatch-Waxman litigation, commercial, and energy law.
Prior to law school, Adam studied spent several years researching total organic synthesis and transition metal catalysis with the Jeon Research Group at the University of Texas at Arlington. Through his studies and research, Adam developed a keen understanding and appreciation for organic chemistry, which he now applies toward assisting clients in complex pharmaceutical litigation.
- “Rhodium-Catalyzed Alkene Hydrosilylation via a Hydride Shuttle Process by Diene Ligands: Dramatic Enhancement of Regio- and Diastereoselectivity,” Yuanda Hua, Hiep H. Nguyen, Gabriela Trog, Adam S. Berlin, Junha Jeon,* Eur. J. Org. Chem. 2014, 5890-5895
- “Mechanistic Insights into Grubbs-Type Ruthenium Complex- Catalyzed Intramolecular Alkene Hydrosilylation: Direct σ-Bond Metathesis in the Initial Stage of Hydrosilylation,” Apparao Bokka, Yuanda Hua, Adam S. Berlin, and Junha Jeon,* ACS Catalysis 2015, 5, 3189-3195